BioWorld

March 7, 2003

View Archived Issues

Mice Sans Cytochrome Gene Have Ocular Drainage Irregularities That Mimic Human Congenital Glaucoma

Interleukin Cedes Majority Interest To Alticor Through Collaboration

Northfield Gets FDA Approval For Phase III Trial Of PolyHeme

PanCel Gets Telomerase License From Geron For Diabetes Program

Other News To Note

Correction

U.S. Patent Disclosures

FDA Head Says Administration Has Hatch-Waxman Under Control

WASHINGTON - FDA Commissioner Mark McClellan told a House subcommittee Thursday that legislation to close loopholes in the Hatch-Waxman Act is not necessary. (BioWorld Today) Read More

ImClone Receives $60M Payment As Part Of Revamped BMS Deal

Today's news in brief

BioWorld

BioWorld briefs for June 15, 2026.

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

Microbiota modulates the antidepressant effects of GLP-1 analogues

BioWorld Science

Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...

Microscopic image of chronic myeloid leukemia

Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

BioWorld

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...